» Articles » PMID: 1875791

Fluoxetine Pretreatment Reduces Breaking Points on a Progressive Ratio Schedule Reinforced by Intravenous Cocaine Self-administration in the Rat

Overview
Journal Life Sci
Publisher Elsevier
Date 1991 Jan 1
PMID 1875791
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Fluoxetine, a specific serotonin re-uptake inhibitor, reduced the breaking points reached by rats on a progressive ratio (PR) schedule reinforced by intravenous cocaine (0.6 mg/inj). This effect was dose-dependent. Specifically, fluoxetine (2.5, 5.0, 10.0, and 20.0 mg/kg, IP) significantly decreased breaking points at all but the lowest dose. These data support a role for the serotonergic system in cocaine reinforcement. We argue that facilitating serotonergic activity reduces the rewarding value of cocaine, thus suggesting an aversive role for serotonin in cocaine reinforcement.

Citing Articles

The role of serotoninergic system in psychostimulant effects.

Taracha E Postep Psychiatr Neurol. 2023; 30(4):258-269.

PMID: 37082555 PMC: 9881639. DOI: 10.5114/ppn.2021.111939.


The Combination of Galanin (1-15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression.

Cantero-Garcia N, Flores-Burgess A, de Guevara-Miranda D, Serrano A, Garcia-Duran L, Puigcerver A Biomedicines. 2022; 10(2).

PMID: 35203621 PMC: 8962322. DOI: 10.3390/biomedicines10020412.


microRNA regulation related to the protective effects of environmental enrichment against cocaine-seeking behavior.

Vannan A, Powell G, DellOrco M, Wilson M, Perrone-Bizzozero N, Neisewander J Drug Alcohol Depend. 2021; 221:108585.

PMID: 33647589 PMC: 8042572. DOI: 10.1016/j.drugalcdep.2021.108585.


The serotonin 5-HT receptor and the non-addictive nature of classic hallucinogens.

Canal C, Murnane K J Psychopharmacol. 2016; 31(1):127-143.

PMID: 27903793 PMC: 5445387. DOI: 10.1177/0269881116677104.


Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor.

Browne C, Fletcher P Neuropsychopharmacology. 2016; 41(10):2566-76.

PMID: 27125304 PMC: 4987855. DOI: 10.1038/npp.2016.63.